Executive Solutions

Healthcare AI Governance for Hospitals & Clinical Leadership

Purpose-built for Chief Medical Officers, Chief Patient Safety Officers, and Hospital AI Steering Committees.

Schedule an Executive Briefing Assess Hospital AI Maturity (EAMA)
Executive Priority

De-Risking AI Adoption in Health Systems

In a 2024 American Hospital Association survey, 52.2% of U.S. hospitals used machine-learning-based predictive AI integrated with their EHR, and 31.5% used generative AI (Everson, Nong and Richwine, JAMA Network Open, 2025). Adoption is moving faster than most governance processes can evaluate subgroup performance.

Synod IntelliCare provides independent retrospective fairness assessments. Our team helps hospital leadership examine how the AI tools they already use perform across patient groups, using de-identified historical data and existing model outputs, with minimal burden on frontline clinical staff.

Core Executive Value Pillars

  • ✔ Independent Retrospective Review: Benchmark commercial AI model outputs on your own de-identified historical data.
  • ✔ Low-Friction Retrospective Assessments: Sidecar assessments use a de-identified extract and require no live EHR integration. Timing depends on data suitability, approvals and a signed scope.
  • ✔ Governance Documentation: Subgroup disparity reporting aligned to emerging governance standards. Not a compliance determination.
  • ✔ Modelled Risk Analysis: Estimate where uncalibrated undertriage patterns may create readmission-penalty exposure (illustrative analysis, not a measured outcome).
Role-Based Value

Built for Every Stakeholder in Healthcare

Select your role below to explore tailored benefits, risk mitigation, and operational value.

Protect Patient Safety & Standardize Clinical AI Governance

Chief Medical Officers and clinical leaders need confidence that algorithms shaping care recommendations are unbiased and reliable across all patient demographics.

  • ✔ Identify where clinical decision models diverge for specific patient subgroups, from a retrospective audit of historical data.
  • ✔ Review documented subgroup performance evidence to inform clinical governance discussions.
  • ✔ Apply standardized equity metrics to the predictive tools under review.
Schedule a CMO Strategy Briefing →